Trials / Completed
CompletedNCT02658188
Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
Long-term Study - Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 182 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy and safety of ASP8825 (gabapentin enacarbil) for long-term treatment of restless legs syndrome patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP8825 | Oral |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2016-01-18
- Last updated
- 2016-02-04
Locations
10 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02658188. Inclusion in this directory is not an endorsement.